Rare focus Target portfolio expansion opportunities by aligning outreach around rare disease therapies and companion diagnostics, leveraging Recordati Rare Diseases’ specialty focus to present tailored value propositions for clinics and specialty pharmacies.

Acquisition momentum Monitor ongoing M&A activity and licensing deals to identify potential co-promotion, distribution, or licensing opportunities for Enjaymo and other rare disease assets in new markets or indications.

Global reach Leverage international procurement and distribution capabilities to propose partnerships with regional distributors, academic medical centers, and patient advocacy groups seeking access to rare disease treatments.

Awareness platforms Engage through awareness campaigns and patient education initiatives to drive demand for orphan therapies, offering support programs, patient services, and clinician education collaborations.

Clinical leadership Leverage the company’s clinical development leadership and medical affairs expertise to pitch joint development programs, real-world evidence studies, and expanded access arrangements with hospitals and payers.